Feline Infectious Peritonitis Therapeutics/Clinical Trials Team
Click here to see our current FIP trials that are recruiting new patients!
Persistence of abdominal or thoracic effusions in cats with wet FIP
Alternative treatments for cats with FIP and natural or acquired resistance to GS-441524
The long history of Beta-d-N4-hydroxycytidine and its modern application to treatment of Covid-19 in people and FIP in cats
The Neurological Form of Feline Infectious Peritonitis and GS-441524 treatment
Treatment of FIP in cats with subcutaneous remdesivir followed by oral GS-441524 tablets
Treatment with oral formulations GS-441524
Treatment of FIP with Remdesivir
Summary of GS-441524 treatment for FIP
Inappropriate use of GS-441524 in an attempt to eliminate FECV from healthy cats
Effects of surgical versus hormonal neutering and routine vaccination on GS-441524 treatment for FIP
Personal statement on GS-441524
Black-market production and sale of GS-441524 and GC376
FIP Therapeutics/Clinical Trials Team is responsible for conducting in-house trials of therapies for naturally occuring FIP.